Research indicates that CranLoad™ provides statistically significant support for healthy flow-mediated dilation (FMD), an effect similar to arginine administration. FMD reflects blood vessel dilation mediated by nitric oxide synthase (NOS), an enzyme that generates the endogenous vasodilator, nitric oxide. In one study, the peak increase in brachial artery diameter following CranLoad™ supplementation was 2.8% at 60 minutes. A similar physiological effect has been demonstrated with arginine. Citrulline is included to support nitric oxide production in the blood vessel endothelium and other tissues. Research indicates that citrulline increases plasma arginine in a dose dependent manner and to a greater degree than arginine supplementation.
CranLoad™ is a trademark used by Pure Encapsulations under license.
Other Ingredients: vegetarian capsule (cellulose, water), ascorbyl palmitate
CranLoad® is a registered trademark used by Pure Encapsulations under license.